Skip to Main Content

Paper Details

Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development: Landscape Analysis of Anticancer Agents Approved from 2015 to 2019.
Clin J Am Soc Nephrol
7
2023
Author NameAffiliation
George Caleb AlexanderCenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health
George Caleb AlexanderJohns Hopkins School of Medicine
Thomas D NolinDepartment of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy
Thomas D NolinUniversity of Pittsburgh School of Medicine
  • 1 - 4

Datasets

Release 1.2